查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白A樹脂市場按產品類型（瓊脂糖基,玻璃/二氧化矽基,有機聚合物基）,類型（重組蛋白A,天然蛋白A）,應用（抗體純化,免疫沉澱）,最終用戶,地區預測至2028
市場調查報告書
商品編碼
1257391

全球蛋白A樹脂市場按產品類型（瓊脂糖基,玻璃/二氧化矽基,有機聚合物基）,類型（重組蛋白A,天然蛋白A）,應用（抗體純化,免疫沉澱）,最終用戶,地區預測至2028

Protein A Resin Market by Product (Agarose-based, Glass/Silica-based, Organic polymer-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), End User & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 145 Pages | 訂單完成後即時交付

價格
簡介目錄

全球蛋白 A 樹脂市場規模預計將從 2022 年的 12 億美元增長到 2028 年的 21 億美元，在預測期內以 9.8% 的複合年增長率增長。

多年來，用於治療的蛋白 A 樹脂帶來的好處不斷增加，這一直是推動市場增長的主要因素之一。

“2022年瓊脂糖基蛋白A樹脂細分市場佔比最大”

基於瓊脂糖的蛋白 A 樹脂市場將在 2022 年佔據最大的市場份額，因為瓊脂糖是用於連接蛋白質結合配體的最廣泛使用的基質樹脂。

“重組蛋白 A 樹脂細分市場將在 2022 年佔據最大市場份額”

按類型劃分，重組蛋白 A 領域預計在 2022 年佔有較大份額，並在預測期內錄得較高的複合年增長率。 這一領域的高速增長可歸因於藥物發現和抗體純化技術的不斷進步。

“抗體純化業務在預測期內將以最高複合年增長率增長”

按應用劃分，抗體純化領域預計將在 2022 年主導市場，並在預測期內實現高複合年增長率。 該細分市場的高速增長主要歸因於下游加工中抗體使用的增加以及對用於治療和研究目的的單克隆抗體 (mAb) 的需求不斷增長。

“製藥和生物製藥公司細分市場在預測期內實現最高複合年增長率”

按最終用戶劃分，製藥和生物製藥公司將在 2022 年佔據最大份額。 據估計，該最終用戶細分市場在預測期內也將以最高複合年增長率增長。 這可能是由於諸如腫瘤,結核病和自身免疫性疾病等不同疾病的治療領域越來越多地使用單克隆抗體等因素造成的。

“2022年北美市場將佔據較大市場份額”

按地區劃分，北美地區的市場預計將在 2022 年佔據重要的市場份額。 該地區蛋白 A 樹脂市場的增長可歸因於藥物研發投資的增加以及政府對研發活動的資助。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 介紹
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 規則
  • 價格分析：蛋白樹脂市場
  • 波特的五力分析

第 6 章蛋白 A 樹脂市場：副產品

  • 介紹
  • 基於瓊脂糖的蛋白 A
  • 玻璃/矽基蛋白 A
  • 基於有機聚合物的蛋白質 A

第 7 章蛋白 A 樹脂市場：按類型分類

  • 介紹
  • 重組蛋白A
  • 天然蛋白A

第 8 章蛋白 A 樹脂市場：按應用

  • 介紹
  • 抗體純化
  • 免疫沉澱

第 9 章蛋白 A 樹脂市場：按最終用戶分類

  • 介紹
  • 製藥和生物製藥公司
  • 教育和研究機構
  • 其他最終用戶

第 10 章蛋白 A 樹脂市場：按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 其他地區 (RoW)

第11章競爭格局

  • 概覽
  • 市場份額分析
  • 競爭領導力映射
  • 競爭場景
    • 產品發布
    • 資本交易
    • 其他趨勢

第12章公司簡介

  • 主要公司
    • DANAHER CORPORATION
    • THERMO FISHER SCIENTIFIC
    • MERCK KGAA
    • REPLIGEN CORPORATION
    • TOSOH BIOSCIENCE LLC
    • AGILENT TECHNOLOGIES, INC.
    • PUROLITE
    • PERKINELMER INC.
    • NOVASEP HOLDING SAS
    • GENSCRIPT
    • BIO-RAD LABORATORIES, INC.
    • KANEKA CORPORATION
    • OROCHEM TECHNOLOGIES INC.
    • ABCAM PLC
    • AGAROSE BEAD TECHNOLOGIES
  • 其他企業
    • AVANTOR, INC.
    • JSR LIFESCIENCES, LLC
    • BIO-WORKS
    • TAKARA BIO INC.
    • GENERON
    • GENO TECHNOLOGY INC.
    • JNC CORPORATION
    • PROMEGA CORPORATION
    • SUZHOU NANOMICRO TECHNOLOGY CO., LTD.
    • TRANSGEN BIOTECH CO., LTD.

第13章 附錄

簡介目錄
Product Code: AST 7818

The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. The rise in advantages offered by protein A resin to be used in therapeutics is one of the major factors anticipated to boost market growth in the forecasting years.

"The agarose-based protein A resin segment to hold the largest share of the market in 2022"

On the basis of product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. The agarose-based protein A segment commanded the largest share of the market in 2022, as agarose is the most widely used matrix resin for the attachment of ligands that bind proteins.

"The recombinant protein A resin segment to hold the largest share of the market in 2022"

On the basis of type, the protein A resin market is segmented into recombinant and natural protein A resin. The recombinant protein A segment accounted for a larger market share in 2022 and is estimated to register a higher CAGR during the forecast period. The high growth of this segment can be attributed to the increasing technological advancements for the discovery of drugs and antibody purifications.

"The antibody purification segment is projected to register the highest CAGR during the forecast period"

Based on application, the protein A resin market is segmented into antibody purification and immunoprecipitation. The antibody purification application segment dominated the market in 2022 and is expected to register a higher CAGR during the forecast period. The high growth of this segment can primarily be attributed to the increasing use in downstream processing of the antibodies and increasing demand for mAbs for therapeutic as well as research purposes.

"The pharmaceutical & biopharmaceutical companies segment is projected to register the highest CAGR during the forecast period"

The end-user market is segmented into pharmaceutical and biopharmaceutical companies, academic research institutes, and other end users. Pharmaceutical and biopharmaceutical companies accounted for the largest share of the global protein A resin market in 2022. This end-user segment is also estimated to grow at the highest CAGR during the forecast period. This can be attributed to the factors such as increasing use for monoclonal antibodies in the therapeutic areas of different diseases like oncology, tuberculosis, and autoimmune diseases.

"The market in the North America region is expected to hold significant market share for protein A resin in 2022."

The protein A resin market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for protein A resin in 2022. The growth of the protein A resin market in this region can be attributed to the increasing investments in pharmaceutical R&D and government funding for R&D activities.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the protein A resin market are Danaher Corporation (US), Merck KGaA (Germany), Repligen Corporation (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), and Tosoh Corporation (Japan) among others.

Research Coverage

This report studies the protein A resin market based on product, type, application, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall C4ISR market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (Need for enhanced integrated situational awareness to support decision making, modernization of defense capabilities to address asymmetric warfare threats, Rising Military focus on wireless connectivity and technologies), restraints (High Development and Maintenance costs of C4 System, Vulnerability to cyberattacks. Regulatory obstacles related to technology transfer), opportunities (Increasing need for interoperability between military devices/technologies. Incraesing use of AI to assist in effective decision making, Cloud computing and data storage solutions for C4ISR), and challenges (Inability of existing electronic warfare systems to address diverse threats) influencing the growth of the C4ISR market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the C4ISR market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the C4ISR market across varied regions
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the C4ISR market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Lockheed Martin Corporation (US), Raytheon Technologies Corporation (US), Thales (France), BAE Systems Inc. (UK), General Dynamics Corporation (US), and Northrop Grumman (US), among others in the C4ISR market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the protein A resin market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the protein A resin market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS AND EXCLUSIONS
  • 1.4 MARKETS COVERED
    • FIGURE 1 MARKET SEGMENTATION
    • 1.4.1 GEOGRAPHIC SEGMENTATION
  • 1.5 YEARS CONSIDERED
  • 1.6 CURRENCY CONSIDERED
  • 1.7 LIMITATIONS
  • 1.8 STAKEHOLDERS
  • 1.9 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RECESSION IMPACT
    • FIGURE 2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key industry insights
      • 2.2.2.3 Breakdown of primaries
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 RESEARCH ASSUMPTION
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 6 MARKET SIZE ESTIMATION: VENDOR REVENUE MAPPING APPROACH
    • FIGURE 7 ANALYSIS OF VENDOR REVENUE MAPPING
      • 2.3.1.2 Approach 2: Customer-based market estimation
    • FIGURE 8 PROTEIN A RESIN MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
      • 2.3.1.3 CAGR projection
    • FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • 2.4 DATA VALIDATION APPROACH
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • 2.7.1 PROTEIN A RESIN MARKET: RISK ASSESSMENT
  • 2.8 GROWTH RATE ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 11 PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION)
    • FIGURE 12 PROTEIN A RESIN MARKET, BY TYPE, 2022 VS. 2028 (USD MILLION)
    • FIGURE 13 PROTEIN A RESIN MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION)
    • FIGURE 14 PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION)
    • FIGURE 15 GEOGRAPHIC SNAPSHOT: PROTEIN A RESIN MARKET

4 PREMIUM INSIGHTS

  • 4.1 PROTEIN A RESIN MARKET OVERVIEW
    • FIGURE 16 INCREASING DEMAND FOR PRE-PACKED DISPOSABLE COLUMNS TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION)
    • FIGURE 17 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD
  • 4.3 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION)
    • FIGURE 18 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO CONTINUE TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD
  • 4.4 GEOGRAPHIC SNAPSHOT OF PROTEIN A RESIN MARKET
    • FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for disposable pre-packed columns
    • TABLE 2 ADVANTAGES OF PRE-PACKED COLUMNS
      • 5.2.1.2 Increasing demand for therapeutic antibodies
      • 5.2.1.3 Increasing pharmaceutical R&D spending
      • 5.2.1.4 Stringent regulatory control in healthcare industry
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of resins
      • 5.2.2.2 Dearth of skilled professionals
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing number of CMOs and CROs
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Regulatory restrictions
      • 5.2.4.2 Issues associated with scaling up production of protein A resins
  • 5.3 REGULATIONS
    • 5.3.1 NORTH AMERICA
      • 5.3.1.1 US
      • 5.3.1.2 Canada
    • 5.3.2 EUROPE
    • 5.3.3 ASIA PACIFIC
    • 5.3.4 LATIN AMERICA
    • 5.3.5 MIDDLE EAST & AFRICA
  • 5.4 PRICING ANALYSIS: PROTEIN A RESIN MARKET
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 PROTEIN A RESIN MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF SUBSTITUTES
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF NEW ENTRANTS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY

6 PROTEIN A RESIN MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 4 PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
  • 6.2 AGAROSE-BASED PROTEIN A
    • 6.2.1 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE MARKET
    • TABLE 5 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2020-2028 (USD MILLION)
    • TABLE 6 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 7 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 8 ASIA PACIFIC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
  • 6.3 GLASS/SILICA-BASED PROTEIN A
    • 6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH
    • TABLE 9 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2020-2028 (USD MILLION)
    • TABLE 10 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 11 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 12 ASIA PACIFIC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
  • 6.4 ORGANIC POLYMER-BASED PROTEIN A
    • 6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH
    • TABLE 13 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2020-2028 (USD MILLION)
    • TABLE 14 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 15 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020-2028 (USD MILLION)

7 PROTEIN A RESIN MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 17 PROTEIN A RESIN MARKET, BY TYPE, 2020-2028 (USD MILLION)
  • 7.2 RECOMBINANT PROTEIN A
    • 7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH
    • TABLE 18 RECOMBINANT PROTEIN A MARKET, BY REGION, 2020-2028 (USD MILLION)
  • 7.3 NATURAL PROTEIN A
    • 7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED MARKET POTENTIAL OF NATURAL PROTEIN A
    • TABLE 19 NATURAL PROTEIN A MARKET, BY REGION, 2020-2028 (USD MILLION)

8 PROTEIN A RESIN MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 20 PROTEIN A RESIN MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
  • 8.2 ANTIBODY PURIFICATION
    • 8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 21 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2020-2028 (USD MILLION)
  • 8.3 IMMUNOPRECIPITATION
    • 8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT LOWER CAGR DURING FORECAST PERIOD
    • TABLE 22 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2020-2028 (USD MILLION)

9 PROTEIN A RESIN MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 23 PROTEIN A RESIN MARKET, BY END USER, 2020-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • 9.2.1 PROTEIN A RESINS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS
    • FIGURE 21 SPENDING ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, 2020-2028 (USD BILLION)
    • TABLE 24 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020-2028 (USD MILLION)
  • 9.3 ACADEMIC RESEARCH INSTITUTES
    • 9.3.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF PROTEIN A RESINS
    • TABLE 25 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2028 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 26 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2020-2028 (USD MILLION)

10 PROTEIN A RESIN MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 27 PROTEIN A RESIN MARKET, BY REGION, 2020-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT
    • TABLE 28 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 29 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • TABLE 30 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2020-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
    • TABLE 32 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2020-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing R&D investments in pharmaceutical industry to propel market growth
    • TABLE 33 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives focused on boosting pharmaceutical industry to drive market growth
    • TABLE 34 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 35 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 36 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • TABLE 37 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2020-2028 (USD MILLION)
    • TABLE 38 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
    • TABLE 39 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2020-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Flourishing biotechnology industry to drive market growth
    • TABLE 40 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Favorable R&D scenario to support market growth
    • TABLE 41 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Favorable healthcare scenario to boost market growth
    • TABLE 42 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Well-established pharmaceutical industry to spur demand for protein A resins
    • TABLE 43 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Presence of large number of biotech R&D service providers to support market growth
    • TABLE 44 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 45 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 23 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT
    • TABLE 46 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2020-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2020-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2020-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption
    • TABLE 51 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing pharmaceutical R&D spending to drive market growth
    • TABLE 52 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growth of pharma and biotech industries to drive demand for protein A resins
    • TABLE 53 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing demand for protein-based therapeutics for treatment of infectious diseases to drive growth
    • TABLE 54 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Developments in biopharmaceutical sector to drive market growth
    • TABLE 55 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 56 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 57 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2020-2028 (USD MILLION)
    • TABLE 58 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2020-2028 (USD MILLION)
    • TABLE 59 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
    • TABLE 60 ROW: PROTEIN A RESIN MARKET, BY END USER, 2020-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS
    • FIGURE 24 PROTEIN A RESIN MARKET SHARE ANALYSIS (2021)
  • 11.3 COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1 STARS
    • 11.3.2 EMERGING LEADERS
    • 11.3.3 PERVASIVE PLAYERS
    • 11.3.4 PARTICIPANTS
    • FIGURE 25 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
  • 11.4 COMPETITIVE SCENARIO
    • 11.4.1 PRODUCT LAUNCHES
    • TABLE 61 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO FEBRUARY 2023
    • 11.4.2 DEALS
    • TABLE 62 PROTEIN A RESIN MARKET: DEALS, JANUARY 2020 TO FEBRUARY 2023
    • 11.4.3 OTHER DEVELOPMENTS
    • TABLE 63 PROTEIN A RESIN MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO FEBRUARY 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 DANAHER CORPORATION
    • TABLE 64 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.2 THERMO FISHER SCIENTIFIC
    • TABLE 65 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 12.1.3 MERCK KGAA
    • TABLE 66 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 12.1.4 REPLIGEN CORPORATION
    • TABLE 67 REPLIGEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 29 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.5 TOSOH BIOSCIENCE LLC
    • TABLE 68 TOSOH BIOSCIENCE LLC: COMPANY OVERVIEW
    • FIGURE 30 TOSOH BIOSCIENCE LLC: COMPANY SNAPSHOT (2021)
    • 12.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 69 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 31 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2022)
    • 12.1.7 PUROLITE
    • TABLE 70 PUROLITE: COMPANY OVERVIEW
    • 12.1.8 PERKINELMER INC.
    • TABLE 71 PERKINELMER INC.: COMPANY OVERVIEW
    • FIGURE 32 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
    • 12.1.9 NOVASEP HOLDING SAS
    • TABLE 72 NOVASEP HOLDING SAS: COMPANY OVERVIEW
    • 12.1.10 GENSCRIPT
    • TABLE 73 GENSCRIPT: COMPANY OVERVIEW
    • FIGURE 33 GENSCRIPT: COMPANY SNAPSHOT (2021)
    • 12.1.11 BIO-RAD LABORATORIES, INC.
    • TABLE 74 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.12 KANEKA CORPORATION
    • TABLE 75 KANEKA CORPORATION: COMPANY OVERVIEW
    • FIGURE 35 KANEKA CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.13 OROCHEM TECHNOLOGIES INC.
    • TABLE 76 OROCHEM TECHNOLOGIES INC.: COMPANY OVERVIEW
    • 12.1.14 ABCAM PLC
    • TABLE 77 ABCAM PLC.: COMPANY OVERVIEW
    • 12.1.15 AGAROSE BEAD TECHNOLOGIES
    • TABLE 78 AGAROSE BEAD TECHNOLOGIES: COMPANY OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER COMPANIES
    • 12.2.1 AVANTOR, INC.
    • 12.2.2 JSR LIFESCIENCES, LLC
    • 12.2.3 BIO-WORKS
    • 12.2.4 TAKARA BIO INC.
    • 12.2.5 GENERON
    • 12.2.6 GENO TECHNOLOGY INC.
    • 12.2.7 JNC CORPORATION
    • 12.2.8 PROMEGA CORPORATION
    • 12.2.9 SUZHOU NANOMICRO TECHNOLOGY CO., LTD.
    • 12.2.10 TRANSGEN BIOTECH CO., LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS